A new method for assessment of plaque vulnerability based on vasa vasorum imaging, by using contrast-enhanced intravascular ultrasound and differential image analysis

International Journal of Cardiology

Volumn 130, Issue 1, 2008, Pages 23-29

  Vavuranakis, Manolis ^a   Kakadiaris, Ioannis A ^b   O'Malley, Sean M ^b   Papaioannou, Theodore G ^a   Sanidas, Elias A ^a   Naghavi, Morteza ^c   Carlier, Stéphane ^d   Tousoulis, Dimitrios ^a   Stefanadis, Christodoulos ^a  

^a Hippokration Hospital   (Greece)

^b University of Houston   (United States)

^c Association for Eradication of Heart Attack   (United States)

^d CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

Author keywords

Contrast agent; Intravascular ultrasound; IVUS; Microbubbles; Neovascularization; Vasa vasorum; Vulnerable plaque

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALGORITHM; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HUMAN; IMAGE ANALYSIS; INTRAVASCULAR ULTRASOUND; MALE; MICROBUBBLE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; VASA VASORUM;

CONTRAST MEDIA; CORONARY ARTERY DISEASE; HUMANS; ULTRASONOGRAPHY, INTERVENTIONAL; VASA VASORUM;

EID: 53549093344     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.170     Document Type: Article

References (23)

1. Naghavi M., Libby P., Falk E., et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108 (2003) 1664-1672
2. Constantinides P. Cause of thrombosis in human atherosclerotic arteries. Am J Cardiol 66 (1990) 37G-40G
3. Burke A.P., Farb A., Malcom G.T., Liang Y.H., Smialek J., and Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 336 (1997) 1276-1282
4. Barger A.C., Beeuwkes R., Lainey L.L., and Silverman K.J. Hypothesis: vasa vasorum and neovascularization of human coronary arteries - a possible role in the pathophysiology of atherosclerosis. N Engl J Med 310 (1984) 175-177
5. Depre C., Havaux X., and Wijns W. Neovascularization in human coronary atherosclerotic lesions. Cathet Cardiovasc Design 39 (1996) 215-220
6. Kolodgie F.D., Burke A.P., Farb A., et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 16 (2001) 285-292
7. Kolodgie F.D., Gold H.K., Burke A.P., et al. Intraplaque hemorrhage and progression of coronary atheroma. N Eng J Med 349 (2003) 2316-2325
8. Numano F. Vasa vasoritis, vasculitis and atherosclerosis. Int J Cardiol 75 Suppl 1 (2000) S1-S8 discussion S17-9
9. Moreno P.R., Purushothaman K.R., Fuster V., et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 110 (2004) 2032-2038
10. Moreno P.R., Purushothaman K.R., Fuster V., and O'Connor W.N. Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: Implications for plaque vulnerability. Circulation 105 (2002) 2504-2511
11. Moulton K.S., Vakili K., Zurakowski D., et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci 100 (2003) 4736-4741
12. Fleiner M., Kummer M., Mirlacher M., et al. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation 110 (2004) 2843-2850
13. Kaiser M., Younge B., Bjornsson J., Goronzy J.J., and Weyand C.M. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 155 (1999) 765-774
14. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 340 (1999) 115-126
15. Feinstein S.B. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol 287 (2004) H450-H457
16. Kaul S. Instrumentation for contrast echocardiography: technology and techniques. Am J Cardiol 90 (2002) 8J-14J
17. Yuan C., Kerwin W.S., Ferguson M.S., et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 15 (2002) 62-67
18. Hirooka K., Yamagishi M., and Miyatake K. Images in cardiology. Visualisation of ablated septal myocardium using myocardial contrast echocardiography in hypertrophic obstructive cardiomyopathy. Heart 84 (2000) 382
19. Carlier S., Kakadiaris I.A., Dib N., et al. Vasa vasorum imaging: a new window to the clinical detection of vulnerable atherosclerotic plaques. Curr Atheroscler Rep 7 (2005) 164-169
20. O'Malley S.M., Vavuranakis M., Naghavi M., and Kakadiaris I.A. Intravascular ultrasound-based imaging of vasa vasorum for the detection of vulnerable atherosclerotic plaque. Proc. Int Conf Med Image Comput Comput Assist Interv 8 (2005) 343-351
21. Vavuranakis M., Kakadiaris I.A., O'Malley S.M., et al. Detection of luminal-intimal border and coronary wall enhancement in intravascular ultrasound imaging after injection of microbubbles and simultaneous sonication with transthoracic echocardiography. Circulation 112 (2005) e1-e2
22. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996) 879-888
23. Quillen J.E., Sellke F.W., Armstrong M.L., and Harrison D.G. Long-term cholesterol feeding alters the reactivity of primate coronary microvessels to platelet products. Arterioscler Thromb 11 (1991) 639-644